Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs.
- Newsx
Related Keywords
Bengaluru , Karnataka , India , Singapore , Chennai , Tamil Nadu , , United States Food Drug Administration , Strides Pharma Science , Strides Pharma Science Limited , Strides Pharma Global , United States Food , Drug Administration , Sucralfate Oral Suspension , Strides Pharma , Oral Suspension , Reference Listed Drug , Sevelamer Carbonate Tablets , Have You Heard About Pink ,
vimarsana.com © 2020. All Rights Reserved.